相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer
Roberto Benelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer
Jian Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
A hnRNP K-AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
Matteo Capaia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update
Guofang Hou et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)
Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma
C. Tang et al.
ONCOGENESIS (2017)
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Nicoletta Ferrari et al.
CELL COMMUNICATION AND SIGNALING (2017)
Aspartate β-Hydroxylase Modulates Cellular Senescence Through Glycogen Synthase Kinase 3β in Hepatocellular Carcinoma
Yoshifumi Iwagami et al.
HEPATOLOGY (2016)
Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
Chiung-Kuei Huang et al.
PLOS ONE (2016)
Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas
Lisa-Marie Sturla et al.
HELIYON (2016)
Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
Di Cui et al.
CLINICAL CANCER RESEARCH (2015)
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
Xiaoqun Dong et al.
ONCOTARGET (2015)
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Naoko Takebe et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
Eleanor Y. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function
Elizabeth Silbermann et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2010)
'Desperate house genes': the dramatic example of hypoxia
J. Caradec et al.
BRITISH JOURNAL OF CANCER (2010)
Aspartyl-(asparaginyl) β-hydroxylase, hypoxia-inducible factor-1α and Notch cross-talk in regulating neuronal motility
Margot Lawton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Deregulated GSK3β Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase
Wei Mai et al.
CLINICAL CANCER RESEARCH (2009)
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target
Stina Haggstrom Rudolfsson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Prognostic value of aspartyl (asparaginyl)-β-hydroxylase/humbug expression in non-small cell lung carcinoma
Martin Luu et al.
HUMAN PATHOLOGY (2009)
Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player
Roberto Benelli et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Notch Signaling: A Potential Therapeutic Target in Prostate Cancer
M. A. Villaronga et al.
CURRENT CANCER DRUG TARGETS (2008)
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Zhong Wang et al.
NATURE (2008)
Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs
Ana Martinez
MEDICINAL RESEARCH REVIEWS (2008)
Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms
M. Chiara Cantarini et al.
HEPATOLOGY (2006)
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Qi Cao et al.
CELL RESEARCH (2006)
Aspartyl-(asparaginyl)-β-hydroxylase regulates hepatocellular carcinoma invasiveness
SM de la Monte et al.
JOURNAL OF HEPATOLOGY (2006)
Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation
XD Wang et al.
DEVELOPMENTAL BIOLOGY (2006)
Role of the aspartyl-asparaginyl-β-hydroxylase gene in neuroblastoma cell motility
PS Sepe et al.
LABORATORY INVESTIGATION (2002)
Oxidative stress signalling in the apoptosis of jurkat T-lymphocytes
R Chiaramonte et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
分享论文
